Molecular basis for amyloid-β polymorphism

Amyloid-beta (Aβ) aggregates are the main constituent of senile plaques, the histological hallmark of Alzheimer’s disease. Aβ molecules form β-sheet containing structures that assemble into a variety of polymorphic oligomers, protofibers, and fibers that exhibit a range of lifetimes and cellular toxicities. This polymorphic nature of Aβ has frustrated its biophysical characterization, its structural determination, and our understanding of its pathological mechanism. To elucidate Aβ polymorphism in atomic detail, we determined eight new microcrystal structures of fiber-forming segments of Aβ. These structures, all of short, self-complementing pairs of β-sheets termed steric zippers, reveal a variety of modes of self-association of Aβ. Combining these atomic structures with previous NMR studies allows us to propose several fiber models, offering molecular models for some of the repertoire of polydisperse structures accessible to Aβ. These structures and molecular models contribute fundamental information for understanding Aβ polymorphic nature and pathogenesis.

[1]  Yves F Dufrêne,et al.  Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. , 2009, The Biochemical journal.

[2]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[3]  David Eisenberg,et al.  Amyloid-like fibrils of ribonuclease A with three-dimensional domain-swapped and native-like structure , 2005, Nature.

[4]  S. Ludtke,et al.  Interprotofilament interactions between Alzheimer's Aβ1–42 peptides in amyloid fibrils revealed by cryoEM , 2009, Proceedings of the National Academy of Sciences.

[5]  David Eisenberg,et al.  Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.

[6]  D. Baker,et al.  The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Tycko,et al.  Evidence for novel beta-sheet structures in Iowa mutant beta-amyloid fibrils. , 2009, Biochemistry.

[8]  P. Hajduk,et al.  Structural characterization of a soluble amyloid beta-peptide oligomer. , 2009, Biochemistry.

[9]  Richard D. Leapman,et al.  Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils , 2005, Science.

[10]  U Aebi,et al.  Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.

[11]  D. Selkoe Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[12]  David Eisenberg,et al.  Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.

[13]  Robert A. Grothe,et al.  Structure of the cross-beta spine of amyloid-like fibrils. , 2005, Nature.

[14]  R. Tycko,et al.  Amyloid of the prion domain of Sup35p has an in-register parallel β-sheet structure , 2006, Proceedings of the National Academy of Sciences.

[15]  M. Inayathullah,et al.  Conformational polymorphism and cellular toxicity of IAPP and βAP domains , 2009 .

[16]  K. Zahs,et al.  Probing the Biology of Alzheimer's Disease in Mice , 2010, Neuron.

[17]  Christiane Ritter,et al.  The mechanism of prion inhibition by HET-S. , 2010, Molecular cell.

[18]  M. Kirschner,et al.  Phosphorylation of microtubule‐associated protein tau: identification of the site for Ca2(+)‐calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. , 1990, The EMBO journal.

[19]  S. Radford,et al.  Fibril fragmentation in amyloid assembly and cytotoxicity , 2010, Prion.

[20]  L. Serrano,et al.  Protein aggregation and amyloidosis: confusion of the kinds? , 2006, Current opinion in structural biology.

[21]  L. Serpell,et al.  Common core structure of amyloid fibrils by synchrotron X-ray diffraction. , 1997, Journal of molecular biology.

[22]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Jayakumar,et al.  Conformational polymorphism and cellular toxicity of IAPP and beta AP domains. , 2009, Journal of structural biology.

[24]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[25]  W. Astbury,et al.  The cross-β configuration in supercontracted proteins , 1959 .

[26]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[27]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[28]  David Eisenberg,et al.  Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.

[29]  David Eisenberg,et al.  A systematic screen of beta(2)-microglobulin and insulin for amyloid-like segments. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Beat H. Meier,et al.  Amyloid Fibrils of the HET-s(218–289) Prion Form a β Solenoid with a Triangular Hydrophobic Core , 2008, Science.

[31]  David Eisenberg,et al.  A systematic screen of β2-microglobulin and insulin for amyloid-like segments , 2006 .

[32]  Kenjiro Ono,et al.  Structure–neurotoxicity relationships of amyloid β-protein oligomers , 2009, Proceedings of the National Academy of Sciences.

[33]  Richard D. Leapman,et al.  Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[34]  A. Takashima,et al.  Surface Structure of Amyloid-β Fibrils Contributes to Cytotoxicity , 2007 .

[35]  N. Grigorieff,et al.  Paired β-sheet structure of an Aβ(1-40) amyloid fibril revealed by electron microscopy , 2008, Proceedings of the National Academy of Sciences.

[36]  A. Takashima,et al.  Surface structure of amyloid-beta fibrils contributes to cytotoxicity. , 2007, Biochemistry.

[37]  G. Glenner,et al.  The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. , 1984, Applied pathology.

[38]  K. Lam,et al.  Congo red and thioflavin-T analogs detect Abeta oligomers. , 2008, Journal of Neurochemistry.

[39]  Ehud Gazit,et al.  Mechanistic studies of the process of amyloid fibrils formation by the use of peptide fragments and analogues: implications for the design of fibrillization inhibitors. , 2002, Current medicinal chemistry.

[40]  David Eisenberg,et al.  Recent atomic models of amyloid fibril structure. , 2006, Current opinion in structural biology.

[41]  H. Kung,et al.  Congo red and thioflavin‐T analogs detect Aβ oligomers , 2007 .

[42]  R. Kayed,et al.  Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct* , 2007, Journal of Biological Chemistry.

[43]  Robert A. Grothe,et al.  An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Fändrich,et al.  Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice , 2008, Journal of Molecular Medicine.

[45]  R. Leapman,et al.  Seeded growth of β-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure , 2009, Proceedings of the National Academy of Sciences.

[46]  E. Gazit Mechanisms of amyloid fibril self‐assembly and inhibition , 2005, The FEBS journal.

[47]  S. Greenberg,et al.  Pathogenic effects of D23N Iowa mutant amyloid beta -protein. , 2001, The Journal of biological chemistry.

[48]  Eric J. Simon,et al.  Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide , 1995, Nature Structural Biology.

[49]  R. Leapman,et al.  Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils , 2000 .

[50]  Y. Ishii,et al.  Evidence of fibril-like β-sheet structures in a neurotoxic amyloid intermediate of Alzheimer's β-amyloid , 2007, Nature Structural &Molecular Biology.

[51]  N. Grigorieff,et al.  Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structures , 2009, Proceedings of the National Academy of Sciences.

[52]  R. Leapman,et al.  Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[53]  K. Sharp,et al.  Intrinsic Linear Heterogeneity of Amyloid β Protein Fibrils Revealed by Higher Resolution Mass-per-length Determinations* , 2010, The Journal of Biological Chemistry.

[54]  David Eisenberg,et al.  Molecular mechanisms for protein-encoded inheritance , 2009, Nature Structural &Molecular Biology.

[55]  Gerd Buntkowsky,et al.  Solid State NMR Reveals a pH-dependent Antiparallel β-Sheet Registry in Fibrils Formed by a β-Amyloid Peptide , 2004 .

[56]  R. Riek,et al.  3D structure of Alzheimer's amyloid-beta(1-42) fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Michela Gallagher,et al.  A specific amyloid-beta protein assembly in the brain impairs memory. , 2006, Nature.

[58]  N. Grigorieff,et al.  Abeta(1-40) fibril polymorphism implies diverse interaction patterns in amyloid fibrils. , 2009, Journal of molecular biology.

[59]  K. Lam,et al.  Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Aβ oligomer-induced cytotoxicity , 2007, Brain Research.

[60]  D. Selkoe,et al.  Alzheimer's Disease: A Central Role for Amyloid , 1994, Journal of neuropathology and experimental neurology.

[61]  R. Wetzel,et al.  Abeta(1-40) forms five distinct amyloid structures whose beta-sheet contents and fibril stabilities are correlated. , 2010, Journal of molecular biology.

[62]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[63]  S. Greenberg,et al.  Pathogenic Effects of D23N Iowa Mutant Amyloid β-Protein* , 2001, The Journal of Biological Chemistry.

[64]  David Eisenberg,et al.  Crystallographic Studies of Prion Protein (PrP) Segments Suggest How Structural Changes Encoded by Polymorphism at Residue 129 Modulate Susceptibility to Human Prion Disease* , 2010, The Journal of Biological Chemistry.

[65]  Adam Douglass,et al.  Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition , 2004, PLoS biology.

[66]  C. Dobson,et al.  High-resolution MAS NMR analysis of PI3-SH3 amyloid fibrils: backbone conformation and implications for protofilament assembly and structure . , 2010, Biochemistry.

[67]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[68]  R. Leapman,et al.  Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. , 2000, Biochemistry.

[69]  S. Kanaya,et al.  Structure of amyloid beta fragments in aqueous environments. , 2006, The FEBS journal.

[70]  D. Selkoe,et al.  X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[71]  David Eisenberg,et al.  Molecular basis for insulin fibril assembly , 2009, Proceedings of the National Academy of Sciences.

[72]  S. Kanaya,et al.  Structure of amyloid β fragments in aqueous environments , 2006 .

[73]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[74]  D. Baker,et al.  Native protein sequences are close to optimal for their structures. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[75]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[76]  M. Kirkitadze,et al.  Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies , 2002, Journal of neuroscience research.

[77]  C. Sachse,et al.  Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils , 2007, Proceedings of the National Academy of Sciences.

[78]  F. Crick,et al.  Is α-Keratin a Coiled Coil? , 1952, Nature.